| 摘要 |
PURPOSE: A pharmaceutical composition which prevents Alzheimer's disease is provided to ensure excellent safety and high body absorption or digestion. CONSTITUTION: A pharmaceutical composition which prevents or treats Alzheimer's disease contains a peptide of sequence number 21 in sequence number 2 as an active ingredient. Peptides of sequence numbers 12-16 are a hydrolysate which is prepared by treating a protein of fish skin with papain or a part of the hydrolystate. Peptides of sequence numbers 17-21 are a hydrolysate which prepared by treating a protein of cuttlefish skin with pepsin, or a part of the hydrolysate. |
